Pain Therapeutics Inc (PTIE) - Financial and Strategic SWOT Analysis Review

June 2018 | 36 pages | ID: PA07E84A4D7EN
GlobalData

Abstracts

Pain Therapeutics Inc (PTIE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Key manufacturing facilities – A list of key manufacturing facilities of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Pain Therapeutics Inc (Pain Therapeutics) is a biopharmaceutical company which focuses on the development and commercialization of novel drugs for treating central nervous system disorders such as chronic pain. The company employs patented abuse-deterrent formulations (ADFs) for the treatment of pain. Its lead drug candidate, Remoxy (oxycodone) is a proprietary, abuse-deterrent, oral formulation of oxycodone (CII) that provides twelve hours of steady pain relief. The company is also developing an abuse-deterrent fentanyl skin patch to treat severe pain, a blood-based diagnostic to detect Alzheimer’s disease (AD), and a proprietary small molecule drug for the treatment of AD. Pain Therapeutics is headquartered in Austin, Texas, the US.

Pain Therapeutics Inc Key Recent Developments

May 09,2018: Pain Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update on REMOXY ER
Feb 05,2018: Pain Therapeutics Reports Financial Results For 2017
Nov 01,2017: Pain Therapeutics Reports Third Quarter 2017 Financial Results
Aug 09,2017: Pain Therapeutics Reports Q2 2017 Financial Results And Mid-year Corporate Update
Apr 25,2017: Pain Therapeutics Reports First Quarter 2017 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Pain Therapeutics Inc - Key Facts
Pain Therapeutics Inc - Key Employees
Pain Therapeutics Inc - Key Employee Biographies
Pain Therapeutics Inc - Major Products and Services
Pain Therapeutics Inc - History
Pain Therapeutics Inc - Company Statement
Pain Therapeutics Inc - Locations And Subsidiaries
Head Office

SECTION 2 – COMPANY ANALYSIS

Company Overview
Pain Therapeutics Inc - Business Description
Pain Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
Pain Therapeutics Inc - Strengths
Pain Therapeutics Inc - Weaknesses
Pain Therapeutics Inc - Opportunities
Pain Therapeutics Inc - Threats
Pain Therapeutics Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

May 09, 2018: Pain Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update on REMOXY ER
Nov 01, 2017: Pain Therapeutics Reports Third Quarter 2017 Financial Results
Aug 09, 2017: Pain Therapeutics Reports Q2 2017 Financial Results And Mid-year Corporate Update
Apr 25, 2017: Pain Therapeutics Reports First Quarter 2017 Financial Results
Feb 17, 2017: Pain Therapeutics Reports 2016 Financial Results

SECTION 5 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Pain Therapeutics Inc, Key Facts
Pain Therapeutics Inc, Key Employees
Pain Therapeutics Inc, Key Employee Biographies
Pain Therapeutics Inc, Major Products and Services
Pain Therapeutics Inc, History
Pain Therapeutics Inc, Key Competitors
Pain Therapeutics Inc, Ratios based on current share price
Pain Therapeutics Inc, Annual Ratios
Pain Therapeutics Inc, Annual Ratios (Cont.1)
Pain Therapeutics Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Pain Therapeutics Inc, Performance Chart (2013 - 2017)
Pain Therapeutics Inc, Ratio Charts

COMPANIES MENTIONED

Alternative technologies
Teva Pharmaceutical Industries Ltd
Roxane Laboratories Inc
Elkins-Sinn Inc
Endo Pharmaceuticals Inc
Purdue Pharma LP
Hikma Pharmaceuticals Plc